Anti-FSD1 antibodies are used in the immunodetection of the protein fibronectin type III and SPRY domain containing 1. In humans, the canonical protein has a reported length of 496 amino acid residues and a mass of 55.8 kDa. Its subcellular localization is in the nucleus and cytoplasm. It is reported to be highly expressed in the brain tissues, including cerebellum, cerebral cortex, medulla, occipital pole, frontal lobe, temporal lobe and putamen. FSD1 is suspected to be involved in microtubule organization and stabilization. Synonyms for this target antigen include MID1-related protein 1, fibronectin type 3 and SPRY (spla, ryanodine) domain containing (with coiled-coil motif) 1, fibronectin type 3 and SPRY domain containing 1, and fibronectin type III and SPRY domain-containing protein 1. FSD1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some FSD1 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. ELISA, Immunofluorescence, and Immunohistochemistry are also common applications.